Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation
- PMID: 16959611
- DOI: 10.1016/j.ccr.2006.08.013
Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation
Abstract
This article investigates the mechanistic aspects of mutant p53 "gain of function" in response to DNA damage. We show that mutant forms of p53 protein interact with NF-Y. The expression of cyclin A, cyclin B1, cdk1, and cdc25C, as well as the cdk1-associated kinase activities, is upregulated after DNA damage, provoking a mutant p53/NF-Y-dependent increase in DNA synthesis. Mutant p53 binds NF-Y target promoters and, upon DNA damage, recruits p300, leading to histone acetylation. The recruitment of mutant p53 to the CCAAT sites is severely impaired upon abrogation of NF-YA expression. Endogenous NF-Y, mutant p53, and p300 proteins form a triple complex upon DNA damage. We demonstrate that aberrant transcriptional regulation underlies the ability of mutant p53 proteins to act as oncogenic factors.
Comment in
-
Mutant p53 gain of function: the NF-Y connection.Cancer Cell. 2006 Sep;10(3):173-4. doi: 10.1016/j.ccr.2006.08.014. Cancer Cell. 2006. PMID: 16959607
Similar articles
-
Mutant p53 gain of function: the NF-Y connection.Cancer Cell. 2006 Sep;10(3):173-4. doi: 10.1016/j.ccr.2006.08.014. Cancer Cell. 2006. PMID: 16959607
-
p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.FEBS Lett. 2005 Feb 14;579(5):1001-7. doi: 10.1016/j.febslet.2004.12.073. Epub 2005 Jan 13. FEBS Lett. 2005. PMID: 15710382
-
p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y.Int J Biochem Cell Biol. 2008;40(10):2110-9. doi: 10.1016/j.biocel.2008.02.010. Epub 2008 Feb 17. Int J Biochem Cell Biol. 2008. PMID: 18372207
-
Transcriptional activities of mutant p53: when mutations are more than a loss.J Cell Biochem. 2004 Nov 15;93(5):878-86. doi: 10.1002/jcb.20271. J Cell Biochem. 2004. PMID: 15449312 Review.
-
Interactions of mutant p53 with DNA: guilt by association.Oncogene. 2007 Apr 2;26(15):2185-90. doi: 10.1038/sj.onc.1210312. Oncogene. 2007. PMID: 17401427 Review.
Cited by
-
A Driver Never Works Alone-Interplay Networks of Mutant p53, MYC, RAS, and Other Universal Oncogenic Drivers in Human Cancer.Cancers (Basel). 2020 Jun 11;12(6):1532. doi: 10.3390/cancers12061532. Cancers (Basel). 2020. PMID: 32545208 Free PMC article. Review.
-
Mutant p53: one name, many proteins.Genes Dev. 2012 Jun 15;26(12):1268-86. doi: 10.1101/gad.190678.112. Genes Dev. 2012. PMID: 22713868 Free PMC article. Review.
-
E2 Ubiquitin-conjugating Enzyme, UBE2C Gene, Is Reciprocally Regulated by Wild-type and Gain-of-Function Mutant p53.J Biol Chem. 2016 Jul 1;291(27):14231-14247. doi: 10.1074/jbc.M116.731398. Epub 2016 Apr 28. J Biol Chem. 2016. PMID: 27129209 Free PMC article.
-
Mutant p53 cooperates with ETS2 to promote etoposide resistance.Genes Dev. 2012 Apr 15;26(8):830-45. doi: 10.1101/gad.181685.111. Genes Dev. 2012. PMID: 22508727 Free PMC article.
-
MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function.Cell Death Differ. 2012 Jun;19(6):1038-48. doi: 10.1038/cdd.2011.190. Epub 2011 Dec 23. Cell Death Differ. 2012. PMID: 22193543 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous